Nkarta Q2 FY26 net loss widens to $40.4 million

Reuters2026/08/10 20:31

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Nkarta posted a net loss of $40.4 million, or $0.54 per share, for Q2 2026.
R&D expense totaled $29 million, while G&A expense was $14.1 million.
Cash, cash equivalents, restricted cash, and investments were $243.2 million at June 30, expected to fund operations into 2029.
Enrollment continued in Ntrust-1 and Ntrust-2 at the 4 billion cell dose level; outpatient dosing began at community-based sites.
Initial clinical data from Ntrust-1 and Ntrust-2 are planned for presentation at a medical conference in 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. nkarta Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-342402), on August 10, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Nkarta Q2 FY26 net loss widens to $40.4 million

You may also like

Crypto prices